
Opinion|Videos|October 18, 2024
Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results
Key Takeaways
- Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response.
- Long-term follow-up data offer valuable insights into the sustained efficacy and safety of lupus nephritis treatments.
Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost-effectiveness in LN management.
Advertisement
Episodes in this series

- How do you monitor patients with lupus nephritis for disease progression and treatment response? (Dr. Larranaga)
- Three-year follow-up results of voclosporin from the AURORA-2 study were
published earlier this year. What is the value of long-term follow-up data such as these in lupus nephritis? (Dr. Wells)
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
4
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
5




